Natera, Inc. (45E)
XETR
286.00
+5.20 (+1.85%)
Closed
Aug 25, 2026
Day's Range
286.00286.00
52 wk Range
185.45286.60
Overview - 45E - Natera, Inc.
Key Statistics
Trading
Volume
30
Average Volume
30
Peers - 45E - Natera, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XETR.
- 45EXETRNatera, Inc.+32.30%52-week change—P/E (Trailing)—Profit Margin
- DAPXETRDanaher Corporation+3.08%52-week change38.88P/E (Trailing)‪15.94%‬Profit Margin
- QTSXETRIQVIA Holdings Inc.+28.69%52-week change128.15P/E (Trailing)‪8.09%‬Profit Margin
- ILUXETRIllumina, Inc.+54.47%52-week change40.73P/E (Trailing)‪18.33%‬Profit Margin
- MTOXETRMettler-Toledo International Inc.+9.45%52-week change32.16P/E (Trailing)‪21.90%‬Profit Margin
- ESF0XETREurofins Scientific SE+5.09%52-week change25.24P/E (Trailing)‪7.17%‬Profit Margin
- NN6XETRNanoRepro AG-5.62%52-week change7.39P/E (Trailing)‪-45.83%‬Profit Margin
Profile Summary - 45E - Natera, Inc.
About
Natera, Inc. is a clinical genetic testing company that focuses on advanced molecular diagnostics using cell-free DNA technology. The company develops and commercializes tests that support clinical decision-making in oncology, women’s health, and organ health, helping physicians tailor care based on genetic insights.…
SectorHealthcare
IndustryDiagnostics & Research
Employees4.42K
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
